SNYR Synergy CHC Corp.: Accounting Value of Company

Public company logo of Synergy CHC Corporation (SNYR)

The Synergy CHC Corp (SNYR) price chart on the GURU.Markets platform illustrates the dynamics of a holding company scaling B2C assets within the self-care niche via social media and marketplaces. The current metric stands at -0.02, as the business competes for profitability against FMCG behemoths amid rising traffic costs. Management efficiency is maintained by outsourcing logistics and product manufacturing to third-party contractors.

SNYR - Synergy CHC Book Capitalization over the range 10/24/2024 - 10/03/2026
Mass-produced product of synergychc.com

The integration of AI into the supply chains and e-commerce brands of Synergy CHC Corp. (SNYR) enables business scaling without increasing personnel costs. This efficiency is reflected in the balance sheet capitalization, which determines the real value of net resources by subtracting liabilities from total assets, allowing the company's historical balance sheet capital to separate fundamental growth from market noise.

Competitor analysis for Synergy CHC Corp

Total Stockholders' Equity Haleon Corp|Kenvue Inc. (KVUE) - Company Book Value|veronapharma.com - Accounting Value of Company|Company Book Value Jyong Biotech|Ligand Pharmaceuticals Incorporated - Net Asset Value|Book Capitalization AMRX|PRGO (Perrigo Corp) - Accounting Value of Company|Book Capitalization ALVO (Alvotech)|Book Capitalization liquidia.com LQDA|GLPG - Company Book Value|Accounting Value of Company ANIP (ANI Pharmaceuticals Inc)|MannKind Corp. (MNKD) - Company Book Value|Company Net Assets Amphastar Corp|PCRX (Pacira BioSciences) - Book Capitalization|Book Capitalization ars-pharma.com|Company Net Assets TBPH (Theravance Biopharma, Inc.)|AQST (Aquestive Therapeutics Inc) - Accounting Value of Company|Company Book Value scPharmaceuticals SCPH|Tectonic Therapeutic Inc. (TECX) - Total Stockholders' Equity|TNXP: Company Net Assets|China SXT Pharmaceuticals - Total Net Assets|EPRX: Book Capitalization|BioHarvest Sciences, Inc. - Accounting Value of Company|EXOZ (Invizyne Technologies, Inc.) - Book Capitalization|Total Stockholders' Equity Oramed Pharma ORMP|Company Book Value Entera Bio Ltd. (ENTX)|HYFT (ipatherapeutics.com) - Accounting Value of Company|Company Book Value ABVC BioPharma, Inc. ABVC|Book Valuation of Business Cumberland Pharmaceuticals Inc (CPIX)|QNTM: Company Net Assets|Total Stockholders' Equity FibroGen Corporation|Telomir Pharmaceuticals (TELO) - Company Book Value|Accounting Capitalization RANI|RLYB (Rallybio Corp) - Book Capitalization|Total Stockholders' Equity Lexaria LEXX|Company Book Value Pulmatrix Corp (PULM)|PTHL (ftzy.com.cn) - Accounting Value of Company|Book Capitalization APM (Aptorum Group)|Book Value of Business lyratherapeutics.com|IBO: Company Net Assets|Total Stockholders' Equity TNF Pharmaceuticals|YCBD (cbdmd.com) - Company Net Assets|PainReform Corp - Accounting Value of Company|CYTO (Altamira Therapeutics Ltd) - Book Capitalization|Company Net Assets lipella.com (LIPO)|Book Capitalization OPTN|PIRS (Pieris Pharmaceuticals Inc) - Accounting Value of Company|Book Capitalization PROC (Procaps Group SA)|PTPI - Company Net Assets|QLI: Company Net Assets|Accounting Value of Company SLRN (acelyrin.com)|TFFP: Book Capitalization